Formaldehyde

Formaldehyde

SCHEMBL8445296

C=O.CCC(N1CCOCC1)S(=O)(=O)O

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
LMNA P02545 3/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.35
TSHR P16473 2/20 0.33
HTT P42858 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
CA12 O43570 1/20 0.33
CA7 P43166 1/20 0.33
CA14 Q9ULX7 1/20 0.33
GAA P10253 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL130983 0.96 ALDH1A1 (0.41) ALDH1A1LMNAMAPTHPGDRAB9A
Hydrochloric Acid SCHEMBL28323474 0.95 ALDH1A1 (0.40) ALDH1A1LMNAMAPTHPGDRAB9A
Hydrochloric Acid SCHEMBL28144653 0.95 ALDH1A1 (0.40) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL30708584 0.95 ALDH1A1 (0.40) ALDH1A1LMNAMAPTHPGDRAB9A
Water SCHEMBL2810013 0.93 ALDH1A1 (0.39) ALDH1A1LMNAMAPTHPGDRAB9A
Tetrahydrofuran SCHEMBL10818635 0.90 LMNA (0.37) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL2586827 0.82
SCHEMBL3691589 0.82 TSHR (0.41) ALDH1A1LMNAMAPTHPGDRAB9A
SCHEMBL28470804 0.82 ALDH1A1 (0.44) ALDH1A1LMNAHPGDKMT2ASMN1; SMN2
SCHEMBL9389700 0.78 CA12 (0.35) ALDH1A1LMNAMAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5968548-A Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) 1999-10-19 US disclosed